Company overview
PBD Biotech develops Actiphage®, a patented phage-based diagnostic technology that detects live mycobacteria, the cause of tuberculosis, in blood samples and other specimens within 8 hours. The test distinguishes viable from non-viable organisms, enabling differentiation between active infections and vaccination responses. Recent innovations include a lyophilized PCR reaction bead for ambient shipping of active TB tests.
Pbd is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include pbd biotech, actiphage, tb diagnostics, phage-based testing, mycobacteria detection.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Pbd include Diagnostic — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://pbdbio.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- pbd biotech, actiphage, tb diagnostics, phage-based testing, mycobacteria detection
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What is Actiphage® and how does it work?
- Actiphage® is PBD Biotech's proprietary phage-based technology that detects extremely low levels of live mycobacteria in blood and other samples from various species, providing results in 8 hours by distinguishing viable organisms from non-viable ones.
- What samples can be used with PBD Biotech's tests?
- The tests work with blood samples primarily for TB screening, and research explores tongue swabs and other biosamples, with studies on timing constraints post-sampling.
- What shipping and storage solutions support PBD Biotech products?
- A new lyophilized PCR reaction bead enables ambient shipping without cold chain requirements, and partnerships like Cryoniss provide safe storage and distribution for TB screening products.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
